CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the updated portfolio of Volusonâ„¢ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results